thinprep pap testtm preservcyt solution (Hologic Inc)
90
Structured Review
Hologic Inc
thinprep pap testtm preservcyt solution
Thinprep Pap Testtm Preservcyt Solution, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/thinprep+pap+testtm+preservcyt+solution/thinprep+pap+testtm+preservcyt+solution/10__1097_slash_lgt__0000000000000564-48-32-37
Average 90 stars, based on 1 article reviews
Thinprep Pap Testtm Preservcyt Solution, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/thinprep+pap+testtm+preservcyt+solution/thinprep+pap+testtm+preservcyt+solution/10__1097_slash_lgt__0000000000000564-48-32-37
Average 90 stars, based on 1 article reviews
thinprep pap testtm preservcyt solution - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Impact of a High Coverage Vaccination Rate on Human Papillomavirus Infection Prevalence in Young Women: A Cross-sectional Study Article Snippet: Objective: The aim of the study was to compare the rate of high-risk human papillomavirus (HR-HPV) genotypes in vaccinated (Gardasil [quadrivalent]) and unvaccinated cohorts of young women.. Materials and Methods: This is a retrospective, cross-sectional study, consisting of the comparison of the prevalence of HPV 16, 18, and other HR genotypes in 2183 women younger than 25 years, according to their birth year (born >1994 [mostly vaccinated <13 years]; born 1992–1994 [vaccinated at 17 years]; born <1992 [not vaccinated/vaccinated >17 years]), in a private laboratory.. Results: The rates of HPV 16, 18, 16/18, and others in the cohort born before 1992 (n = 331) were 6.3%, 1.5%, 7.9%, and 31.7%. |